Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (2)
• Saliva (1)
• Serum (3)
• Stool (2)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (1)
• Non-affected (1)
• Not applicable (6)

Storage Temperature

• -35°C to -18°C (4)
• -85°C to -60°C (4)
• Liquid nitrogen (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (2)
• Followup records (3)
• Freezer temperature logs (4)
• Genomic datasets (2)
• Imaging data (2)
• Microbiological results (4)
• Participant Ethnicity (1)
• Pre-analytical data (1)
• Quality indicators (1)
• Survey data (6)
• Treatment records (3)

Timeframe

• Immediate (1)
• 0 - 3 months (6)
• 3 - 6 months (2)
• > 6 months (2)

Participant Count

• 1 - 10 (1)
• 11 - 100 (6)
• 101 - 500 (2)

Sex

• Both sexes (8)

Age Range

• Adolescent (12 - 18 years) (8)

Biobank Services

• Cell culture (1)
• Infectious strain isolation (2)
• Molecular Extractions (1)
• Nucleic acid extraction (3)

Collection Type

• Case-control (1)
• Clinical Trial (1)
• Cohort (1)
• Cross-sectional (2)
• Disease specific (4)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (8)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (7)
• No Scope of use restriction (7)

Collection Status

• Completed (3)
• In progress (5)
• Not-started (1)

Access Condition

• Open to applicants (2)
• Open only through collaboration (4)
• Access restricted at present (2)

Country

• Belgium (1)
• Cameroon (1)
• Côte d'Ivoire (1)
• France (1)
• Ghana (2)
• India (1)
• United States (1)

County